Nhut Le

785 total citations
24 papers, 588 citations indexed

About

Nhut Le is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Nhut Le has authored 24 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 17 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Nhut Le's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (6 papers). Nhut Le is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (6 papers). Nhut Le collaborates with scholars based in United States, Nigeria and Canada. Nhut Le's co-authors include Alonso Heredia, Robert Redfield, Robert C. Gallo, Charles E. Davis, Olga Latinovic, Mohammad M. Sajadi, Juan Carlos Zapata, Anthony L. DeVico, Sandra Medina-Moreno and Gregory B. Melikyan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Nhut Le

23 papers receiving 581 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nhut Le 351 289 174 110 107 24 588
Leila B. Giron 148 0.4× 283 1.0× 190 1.1× 98 0.9× 243 2.3× 39 644
Brett S. Robinson 424 1.2× 445 1.5× 61 0.4× 57 0.5× 169 1.6× 9 633
Samandhy Cedeño 240 0.7× 230 0.8× 182 1.0× 74 0.7× 121 1.1× 32 544
T.M. Jenkins 698 2.0× 585 2.0× 177 1.0× 149 1.4× 338 3.2× 11 1.0k
Caroline Passaes 532 1.5× 406 1.4× 190 1.1× 148 1.3× 154 1.4× 28 770
Malcolm Macartney 663 1.9× 523 1.8× 217 1.2× 213 1.9× 284 2.7× 19 1.1k
Joshua Goldsmith 209 0.6× 228 0.8× 41 0.2× 52 0.5× 74 0.7× 4 321
Geneviève Laflamme 117 0.3× 336 1.2× 76 0.4× 105 1.0× 230 2.1× 18 583
Britt Stancil 329 0.9× 455 1.6× 86 0.5× 207 1.9× 66 0.6× 12 850
Beatrice Kallungal 441 1.3× 390 1.3× 122 0.7× 73 0.7× 75 0.7× 7 636

Countries citing papers authored by Nhut Le

Since Specialization
Citations

This map shows the geographic impact of Nhut Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nhut Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nhut Le more than expected).

Fields of papers citing papers by Nhut Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nhut Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nhut Le. The network helps show where Nhut Le may publish in the future.

Co-authorship network of co-authors of Nhut Le

This figure shows the co-authorship network connecting the top 25 collaborators of Nhut Le. A scholar is included among the top collaborators of Nhut Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nhut Le. Nhut Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Le, Nhut, et al.. (2022). Human Hematopoietic Stem Cell (HSC)-Engrafted NSG Mice for HIV Latency Research. Methods in molecular biology. 2407. 229–251. 2 indexed citations
3.
Medina-Moreno, Sandra, Thomas C. Dowling, Juan Carlos Zapata, et al.. (2017). Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice. PLoS ONE. 12(8). e0183425–e0183425. 16 indexed citations
4.
Heredia, Alonso, Said Hassounah, Sandra Medina-Moreno, et al.. (2017). Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice. Journal of Antimicrobial Chemotherapy. 72(9). 2570–2573. 12 indexed citations
5.
Heredia, Alonso, Nhut Le, Ronald B. Gartenhaus, et al.. (2015). Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice. Proceedings of the National Academy of Sciences. 112(30). 9412–9417. 79 indexed citations
6.
Heredia, Alonso, Charles E. Davis, M S Reitz, et al.. (2013). Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir Against Sensitive and Drug-Resistant HIV-1. The Journal of Infectious Diseases. 208(12). 2085–2094. 14 indexed citations
7.
Heredia, Alonso, Charles E. Davis, Mohammed A. Amin, et al.. (2013). Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1. AIDS. 28(3). 317–323. 22 indexed citations
8.
Latinovic, Olga, Nhut Le, Marvin S. Reitz, et al.. (2011). Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention. AIDS. 25(9). 1232–1235. 11 indexed citations
9.
Latinovic, Olga, Marvin S. Reitz, Nhut Le, et al.. (2011). CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells. Virology. 411(1). 32–40. 15 indexed citations
10.
Latinovic, Olga, et al.. (2009). Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonists. Antiviral Research. 83(1). 86–89. 13 indexed citations
11.
Latinovic, Olga, Janaki Kuruppu, Charles E. Davis, Nhut Le, & Alonso Heredia. (2009). Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc. PubMed. 1. 1497–1510. 22 indexed citations
12.
Sajadi, Mohammad M., et al.. (2007). HIV-1 natural viral suppressors: control of viral replication in the absence of therapy. AIDS. 21(4). 517–519. 68 indexed citations
13.
Heredia, Alonso, Bruce L. Gilliam, Anthony L. DeVico, et al.. (2007). CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1. AIDS. 21(10). 1317–1322. 36 indexed citations
14.
Heredia, Alonso, Bruce L. Gilliam, Olga Latinovic, et al.. (2007). Rapamycin Reduces CCR5 Density Levels on CD4 T Cells, and This Effect Results in Potentiation of Enfuvirtide (T-20) against R5 Strains of Human Immunodeficiency Virus Type 1 In Vitro. Antimicrobial Agents and Chemotherapy. 51(7). 2489–2496. 24 indexed citations
15.
Gilliam, Bruce L., Alonso Heredia, Anthony L. DeVico, et al.. (2007). Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment. AIDS. 21(15). 2108–2110. 28 indexed citations
16.
Heredia, Alonso, Charles E. Davis, Nhut Le, et al.. (2005). Indirubin-3′-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. AIDS. 19(18). 2087–2095. 55 indexed citations
17.
Wang, Jingsong, Nhut Le, Alonso Heredia, et al.. (2005). Modification and structure–activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120. Organic & Biomolecular Chemistry. 3(9). 1781–1781. 24 indexed citations
18.
Heredia, Alonso, et al.. (2005). In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implications. AIDS. 19(8). 836–837. 5 indexed citations
19.
Heredia, Alonso, Charles E. Davis, Anthony Amoroso, et al.. (2003). Induction of G 1 cycle arrest in T lymphocytes results in increased extracellular levels of β-chemokines: A strategy to inhibit R5 HIV-1. Proceedings of the National Academy of Sciences. 100(7). 4179–4184. 26 indexed citations
20.
Heredia, Alonso, David M. Margolis, David Oldach, et al.. (1999). Abacavir in Combination With the Inosine Monophosphate Dehydrogenase (IMPDH)–Inhibitor Mycophenolic Acid Is Active Against Multidrug-Resistant HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(4). 406–406. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leila B. Giron Breakdown of academic impact, for papers by Brett S. Robinson Breakdown of academic impact, for papers by Samandhy Cedeño Breakdown of academic impact, for papers by T.M. Jenkins Breakdown of academic impact, for papers by Caroline Passaes Breakdown of academic impact, for papers by Malcolm Macartney Breakdown of academic impact, for papers by Joshua Goldsmith Breakdown of academic impact, for papers by Geneviève Laflamme Breakdown of academic impact, for papers by Britt Stancil Breakdown of academic impact, for papers by Beatrice Kallungal
Rankless by CCL
2026